209 related articles for article (PubMed ID: 26158764)
1. Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling.
Harazono Y; Kho DH; Balan V; Nakajima K; Hogan V; Raz A
Oncotarget; 2015 Aug; 6(23):19592-604. PubMed ID: 26158764
[TBL] [Abstract][Full Text] [Related]
2. [Synergic effect of Na(+)-K(+) ATPaseB1 and adriamycin on inhibition of cell proliferation and reversal of drug resistance in breast cancer MCF-7 cells].
Qi YY; Liu K; Zhang J; Li K; Ren JJ; Lin P
Ai Zheng; 2009 Aug; 28(8):861-7. PubMed ID: 19664334
[TBL] [Abstract][Full Text] [Related]
3. CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription.
Xia Z; Guo M; Liu H; Jiang L; Li Q; Peng J; Li JD; Shan B; Feng P; Ma H
Curr Cancer Drug Targets; 2015; 15(6):519-32. PubMed ID: 25968898
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of signal transduction by Na-K-ATPase α-isoforms: role of Src interaction.
Yu H; Cui X; Zhang J; Xie JX; Banerjee M; Pierre SV; Xie Z
Am J Physiol Cell Physiol; 2018 Feb; 314(2):C202-C210. PubMed ID: 29118027
[TBL] [Abstract][Full Text] [Related]
6. Purinergic agonists stimulate lens Na-K-ATPase-mediated transport via a Src tyrosine kinase-dependent pathway.
Tamiya S; Okafor MC; Delamere NA
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C790-6. PubMed ID: 17522142
[TBL] [Abstract][Full Text] [Related]
7. Zhankuic Acids A, B and C from
Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
[No Abstract] [Full Text] [Related]
8. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
[TBL] [Abstract][Full Text] [Related]
9. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
10. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
12. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
13. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
14. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
[No Abstract] [Full Text] [Related]
15. Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway.
Wang F; Lv P; Gu Y; Li L; Ge X; Guo G
Oncotarget; 2017 Apr; 8(15):25097-25106. PubMed ID: 28212576
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na(+)/K(+)-ATPase.
Zeino M; Brenk R; Gruber L; Zehl M; Urban E; Kopp B; Efferth T
J Steroid Biochem Mol Biol; 2015 Jun; 150():97-111. PubMed ID: 25797029
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Apolipoprotein E Enhanced Sensitivity of Hep3B Cells to Cardiac Steroids via Regulating Na+/K+-ATPase Signalosome.
Liu M; Feng LX; Sun P; Liu W; Mi T; Lei M; Wu W; Jiang B; Yang M; Hu L; Guo DA; Liu X
Mol Cancer Ther; 2016 Dec; 15(12):2955-2965. PubMed ID: 27507851
[TBL] [Abstract][Full Text] [Related]
18. Wilforine resensitizes multidrug resistant cancer cells via competitive inhibition of P-glycoprotein.
Chang YT; Lin YC; Sun L; Liao WC; Wang CCN; Chou CY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2020 Jun; 71():153239. PubMed ID: 32447245
[TBL] [Abstract][Full Text] [Related]
19. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
20. Binding of Src to Na+/K+-ATPase forms a functional signaling complex.
Tian J; Cai T; Yuan Z; Wang H; Liu L; Haas M; Maksimova E; Huang XY; Xie ZJ
Mol Biol Cell; 2006 Jan; 17(1):317-26. PubMed ID: 16267270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
